Julien George Roth

Stem Cell Bio. PhD in the Heilshorn Lab @Stanford | Neuroscience, Biomaterials, 3D Bioprinting | @NSF and SGF Fellow

[Heilshorn Lab @heilshornlab]

We have a new publication by @Julien_G_Roth and @michshuang in @ScienceAdvances on how viscoelasticity influences neural maturation! 🧠 Head over to @michshuang's tweet for a detailed thread summary 🧵:

[Heilshorn Lab @heilshornlab]

So excited to share our paper introducing Spatially Patterned Organoid Transfer (SPOT), now out at @NatureComms! Led by @Julien_G_Roth, we present a platform for spatially controlling the fabrication of multi-organoid #assembloids using bioprinting.

https://t.co/J3KDIMp745
(1/n)

[Julien George Roth @Julien_G_Roth]

A big thank you to the team at the @heilshornlab and our collaborators @Sergiu_P_Pasca and the Fan Yang Lab!

[Julien George Roth @Julien_G_Roth]

Our preprint on leveraging #3Dprinting to construct stem-cell derived models of human brain development and disease is up on @researchsquare: https://t.co/D2JxWFEMKW

[Julien George Roth @Julien_G_Roth]

Interested in #vaccines and/or #biomaterials? Check out this comprehensive, timely, and beautifully illustrated review from @GillieAgmon and @AppelGroup in @NatRevMater! https://t.co/yVNRkg4mGW

[Julien George Roth @Julien_G_Roth]

If you're a fan of beautiful figures and a very interesting perspective on in vitro cancer models, check out this new review!

[Julien George Roth @Julien_G_Roth]

A big thanks to all our amazing co-authors @heilshornlab @PascaStanford @zhenanbao @HankGreelyLSJU @BianxiaoC Yuanwen Jiang @vivianfeig @ThomasLetaoLi and @michshuang

[Julien George Roth @Julien_G_Roth]

Interested in learning about how biomaterials guide human brain development? Our review in @NatRevNeurosci covers that and much more: https://t.co/SNwCsjG3UG

[Sergiu P. Pasca @Sergiu_P_Pasca]

Latest article is in @NatRevNeurosci today. Effort led by the talented @Julien_G_Roth!
#assembloids #organoids #brain #biomaterials
https://t.co/CsTyNEw1U5

[Heilshorn Lab @heilshornlab]

We're on Twitter! Stay tuned for news and updates about upcoming talks, recent publications, and group news! And yes, that is a smiling organoid 😀

[Julien George Roth @Julien_G_Roth]

Imagine if proteins were cats (and other tips for creating scientific illustrations which capture your audience's attention).

[Nature Portfolio @NaturePortfolio]

Science often benefits from good illustration and graphic design, but most scientists never receive any formal training. Nature sought advice from three people with experience in scientific illustration. https://t.co/1TD1EKyag2

[Julien George Roth @Julien_G_Roth]

Some really great work from @themasap and @PascaStanford on the physiological repercussions of genetic abnormalities in human neural organoids is now available in press! Congratulations! https://t.co/4r49Nj3q0Q

[Julien George Roth @Julien_G_Roth]

For those interested in reading an interesting take on the recent @illumina deal to acquire @GrailBio!

[Charles Roberts @CCRobertsARK]

Illumina ($ILMN) Acquires GRAIL: Pros, Cons, & Questions

Earlier today, Illumina announced its intent to acquire cancer-screening company GRAIL for $8 billion, marking its most direct foray into clinical #genetics.

Here's what we think:

🔗: https://t.co/FagRdAeNgU

[Julien George Roth @Julien_G_Roth]

Big congratulations to @GillieAgmon and co. for putting together this impressive paper!

[Eric A. Appel @AppelGroup]

Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity @ACSCentSci - “this work introduces a simple and effective vaccine delivery platform that increases the potency and durability of subunit vaccines” https://t.co/I6tVjLbdK1

[Julien George Roth @Julien_G_Roth]

Although the data needs careful review (independent genome sequencing), scientists in China may have helped create the world's first genome-edited human babies. https://t.co/06tT0DNzQ2

[StanfordBiotechGroup @stanfordbiotech]

Happening right now: Life After Academia!

[Julien George Roth @Julien_G_Roth]

On September 12th, System1 Biosciences announced the completion of $25M in Series A financing. Looking forward to seeing how they move forward! @System1Bio @pfizer @CRV
https://t.co/A7i6uHpV64 via @WSJ